Triple

T4050932
Position Surface form Disambiguated ID Type / Status
Subject Gilead Sciences E84182 entity
Predicate product P490 FINISHED
Object Epclusa
Epclusa is a prescription antiviral medication used to treat chronic hepatitis C infection across all major genotypes.
 E413592 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Epclusa | Statement: [Gilead Sciences, product, Epclusa]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: Epclusa
Context triple: [Gilead Sciences, product, Epclusa]
  • A. Harvoni
    Harvoni is a prescription antiviral medication used to treat chronic hepatitis C virus (HCV) infection.
  • B. Sovaldi
    Sovaldi is a breakthrough antiviral medication used to treat chronic hepatitis C by directly inhibiting the virus’s replication.
  • C. Waylivra
    Waylivra is a prescription antisense oligonucleotide therapy used to treat familial chylomicronemia syndrome (FCS) by reducing triglyceride levels in the blood.
  • D. Descovy
    Descovy is a prescription antiretroviral medication from Gilead Sciences used for the treatment and prevention (PrEP) of HIV-1 infection.
  • E. Truvada
    Truvada is a prescription antiretroviral medication widely used both to treat HIV infection and as pre-exposure prophylaxis (PrEP) to help prevent HIV in high-risk individuals.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Epclusa
Triple: [Gilead Sciences, product, Epclusa]
Generated description
Epclusa is a prescription antiviral medication used to treat chronic hepatitis C infection across all major genotypes.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07 
Target entity: Epclusa
Target entity description: Epclusa is a prescription antiviral medication used to treat chronic hepatitis C infection across all major genotypes.
  • A. Harvoni
    Harvoni is a prescription antiviral medication used to treat chronic hepatitis C virus (HCV) infection.
  • B. Sovaldi
    Sovaldi is a breakthrough antiviral medication used to treat chronic hepatitis C by directly inhibiting the virus’s replication.
  • C. Waylivra
    Waylivra is a prescription antisense oligonucleotide therapy used to treat familial chylomicronemia syndrome (FCS) by reducing triglyceride levels in the blood.
  • D. Descovy
    Descovy is a prescription antiretroviral medication from Gilead Sciences used for the treatment and prevention (PrEP) of HIV-1 infection.
  • E. Truvada
    Truvada is a prescription antiretroviral medication widely used both to treat HIV infection and as pre-exposure prophylaxis (PrEP) to help prevent HIV in high-risk individuals.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69aed930bd5c819083e7dcc14fc44f69 completed March 9, 2026, 2:29 p.m.
NER Named-entity recognition batch_69aefb8539148190990468c1429be9dd completed March 9, 2026, 4:55 p.m.
NED1 Entity disambiguation (via context triple) batch_69b56b501c008190ac115240328c6fc9 completed March 14, 2026, 2:06 p.m.
NEDg Description generation batch_69b56f1a5e348190801c63c00b838f3c completed March 14, 2026, 2:22 p.m.
NED2 Entity disambiguation (via description) batch_69b56f7f1f7881909c8003e4e498fac5 completed March 14, 2026, 2:23 p.m.
Created at: March 9, 2026, 3:37 p.m.